Sage Journals: Discover world-class research

Abstract

Marketing authorization holders should report adverse drug reactions (ADRs) derived from spontaneous case reports and literature for their medicinal products to competent authorities. Yet the difference in quality of data from both sources has never been analyzed. To this end, YES Pharmaceutical Development Services in cooperation with the German Medicines Manufacturers Association has conducted an analysis examining more than 25,100 spontaneous and literature cases that occurred between 2007 and 2008. Reporting rates of ADRs for specific drug substances (DSs), expectedness, and the system organ class (SOC) referred to were examined. It was found that the distribution of ADRs to specific SOCs differs between both groups for selected DSs. For more than 37% of the DSs being evaluated, a difference of 10% or more regarding reporting rates of unexpected ADRs was observed between both groups. These findings underline the substantial importance of regular literature reviews in addition to the spontaneous reporting system for a sufficient safety assessment of medicinal products.

Keywords

spontaneous case reports literature cases adverse drug reactions expectedness

Get full access to this article

View all access options for this article.

References

Hauben

. Signal detection in the pharmaceutical industry: integrating clinical and computational approaches. Drug Saf. 2007;30:627–630.

Hauben

Reich

. A case report of rhabdomyolysis with pentamidine that prompted a retrospective evaluation of a pharmacovigilance tool under investigation. Br J Clin Pharmacol. 2004;58:675–676.

Newcombe

. Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat Med. 1998;17:873–890.

Haramburu

Bégaud

Moride

. Temporal trends in spontaneous reporting of unlabelled adverse drug reactions. Br J Clin Pharmacol. 1997;44:299–301.

Olivier

Montastruc

. The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France. Pharmacoepidemiol Drug Saf. 2006;15:808–812.

Tavassoli

Lapeyre-Mestre

Sommet

Montastruc

. Reporting rate of adverse drug reactions to the French pharmacovigilance system with three step 2 analgesic drugs: dextro-propoxyphene, tramadol and codeine (in combination with paracetamol). Br J Clin Pharmacol. 2009;68:422–426.

Kopečná

Deščíková

Vlček

Mladá

. Adverse drug reaction reporting in the Czech Republic 2005-2009. Int J Clin Pharm. 2011;33:683–689.

Pariente

Gregoire

Fourrier-Reglat

Haramburu

Moore

. Impact of safety alerts on measures of disproportionality in spontaneous reporting databases: the notoriety bias. Drug Saf. 2007;30:891–898.

Kelly

Arellano

Barnes

. Guidelines for submitting adverse event reports for publication. Pharmacoepidemiol Drug Saf. 2007;16:581–587.

10.

Impicciatore

Mucci

. Completeness of published case reports on suspected adverse drug reactions: evaluation of 100 reports from a company safety database. Drug Saf. 2010;33:765–773.

11.

Thiessard

Roux

Miremont-Salamé

. Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001). Drug Saf. 2005;28:731–740.

12.

Chang

Campbell

. Intraoperative floppy iris syndrome associated with tamsulosin. J Cataract Refract Surg. 2005;3:664–673.

Safety Information From Spontaneous and Literature Adverse Reaction Reports

Abstract

Keywords

Get full access to this article

References